HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ganglioneuroblastoma

A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.
Also Known As:
Ganglioneuroblastomas
Networked: 169 relevant articles (0 outcomes, 9 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neuroblastoma
2. Pheochromocytoma
3. Neoplasms (Cancer)
4. Ganglioneuroma
5. Vipoma (WDHA)

Experts

1. Angelini, Paola: 2 articles (02/2015 - 06/2003)
2. Kofler, Barbara: 2 articles (09/2013 - 01/2006)
3. Shibahara, Shigeki: 2 articles (02/2003 - 06/2002)
4. Murakami, Osamu: 2 articles (02/2003 - 06/2002)
5. Hayashi, Yutaka: 2 articles (02/2003 - 06/2002)
6. Totsune, Kazuhito: 2 articles (02/2003 - 06/2002)
7. Takahashi, Kazuhiro: 2 articles (02/2003 - 06/2002)
8. Noshiro, Takao: 2 articles (02/2003 - 06/2002)
9. Totsune, K: 2 articles (01/2001 - 04/2000)
10. Hayashi, Y: 2 articles (01/2001 - 04/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Ganglioneuroblastoma:
1. Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
2. Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
3. Adrenocorticotropic Hormone (ACTH)FDA Link
4. WDHA syndromeIBA
5. Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
6. Substance PIBA
7. RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
8. PeptidesIBA
9. Corticotropin-Releasing HormoneIBA
10. Cyclin D1IBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Adrenalectomy
3. Transplants (Transplant)
4. Sympathectomy (Sympathectomies)
5. Radiotherapy